Stroke prevention by low-dose anticoagulation in patients with heart failure and sinus rhythm: is it worth the effort?

Affiliations

¹ ANMCO Research Center, Heart Care Foundation, Via La Marmora 34, Florence, Italy.
² Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University, Rome, Italy.

Editorial

Aldo P Maggioni et al. Eur Heart J. 2019.

. 2019 Nov 21;40(44):3602-3604.

doi: 10.1093/eurheartj/ehz523.

¹ ANMCO Research Center, Heart Care Foundation, Via La Marmora 34, Florence, Italy.
² Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University, Rome, Italy.

No abstract available

Comment on

A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial.
Mehra MR, Vaduganathan M, Fu M, Ferreira JP, Anker SD, Cleland JGF, Lam CSP, van Veldhuisen DJ, Byra WM, Spiro TE, Deng H, Zannad F, Greenberg B. Mehra MR, et al. Eur Heart J. 2019 Nov 21;40(44):3593-3602. doi: 10.1093/eurheartj/ehz427. Eur Heart J. 2019. PMID: 31461239 Free PMC article. Clinical Trial.